MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
Kenneth K.W. To(Chinese University of Hong Kong), William C. Cho(Queen Elizabeth Hospital)
Cited by 205
Related Papers
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine
|Cancer Cell International|2022|447
Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1
|Journal of Biological Chemistry|2005|113
Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonists
|British Journal of Pharmacology|2013|35
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
|Scientific Reports|2016|10
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition
|ACS Pharmacology & Translational Science|2023|8